Latest technology reporting
Evidence-led coverage of biotechnology, AI infrastructure, energy, robotics, devices and brain–computer interfaces.
-
The Designer-Baby Debate Is Moving Beyond Gene Editing
A new ethics correspondence argues that embryo editing and selection need joint governance. Polygenic screening already puts prediction, marketing and oversight in conflict.
-
AI Companions Face a Loneliness Warning From a New Teen Study
A researcher’s account of a study still under review raises concerns about AI companionship. Peer-reviewed work shows why the evidence needs careful handling.
-
Amazon’s US$1 Billion Promise Raises the Stakes in the Data-Centre Fight
Amazon’s new community programme puts education, energy savings and local funding on the table. Delivering those benefits is a separate test from announcing them.
-
Australia’s AI Cyber Incident Turns Safety Promises Into an Accountability Test
A government review follows unauthorised activity by a non-public AI model. The dispute is now about who sets the boundaries—and who checks them.
-
Amazon’s Nuclear Deal Targets More Power From Reactors Already Running
Amazon is backing a planned upgrade at Maryland’s Calvert Cliffs nuclear plant. The agreement shows how demand for computing power can support existing reactors, with added output still years away.
-
Sydney’s Scrapped Data Centre Exposes a Bottleneck Beyond Electricity
Goodman has withdrawn its Project Mars data-centre application in Lane Cove. The decision highlights the planning and community acceptance needed alongside power and hardware.
-
A New Ageing Theory Puts Cells’ Lost Identity Under the Microscope
A new Nature review proposes that ageing partly reflects the gradual erosion of the rules that keep cells specialised. It offers testable ideas, not a rejuvenation result.
-
AMD’s AI Rack Challenge Wins a US$1.2 Billion Customer
HPE has announced its first AMD Helios order, from cloud provider Vultr. The deal puts complete racks, networking and cooling at the centre of the AI hardware contest.
-
An Australian Virus Therapy Is Taking Aim at Hard-to-Treat Bowel Cancer
ImmVirX plans a more focused trial of its oncolytic RNA-virus therapy after early human studies. The Phase II programme still depends on further financing.
-
A One-Megawatt ‘Nuclear Battery’ Is Heading for a Full-Power Test
Idaho National Laboratory has selected Deployable Energy for a planned 2027 microreactor test. Full-power performance and commercial deployment remain separate milestones.
-
The AI Boom Is Becoming a Memory-Chip Boom
Micron’s latest results show the scale of demand for memory and storage. New sampling and shipment milestones reveal the engineering work behind the numbers.
-
An RNA Injection Is Testing a Different Route Through Skin Cancer
A small Phase IIb study reported responses to an RNA-based injection for basal cell carcinoma. Surgery remained in the protocol, and the treatment is unapproved.